Isolation and characterization of a xylose-glucose isomerase from a new strain Streptomyces thermovulgaris 127, var. 7-86. 2001

V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
Institute of Microbiology, Bulgarian Academy of Sciences, Sofia.

A thermostable D-xylose-glucose isomerase was isolated from the thermophilic strain Streptomyces thermovulgaris 127, var. 7-86, as a result of mutagenic treatment by gamma-irradiation of the parent strain, by precipitation and sequential chromatographies on DEAE-Sephadex A50, TSK-gel, FPLC-Mono Q/HR, and Superose 12 columns. The N-terminal amino acid sequence and amino acid analysis shows 73-92% homology with xylose-glucose isomerases from other sources. The native molecular mass, determined by gel filtration on a Superose 12 column, is 180 kDa, and 44.6 and 45 kDa were calculated, based on amino acid analysis and 10% SDS-PAGE, respectively. Both, the activity and stability of the enzyme were investigated toward pH, temperature, and denaturation with guanidine hydrochloride. The enzyme activity showed a clear pH optimum between pH 7.2 and 9.0 with D-glucose and 7.4 and 8.3 with D-xylose as substrates, respectively. The enzyme is active up to 60-85 degrees C at pH 7.0, using D-glucose, and up to 50-60 degrees C at pH 7.6, using D-xylose as substrates. The activation energy (Ea = 46 kJ x mol(-1)) and the critical temperature (Tc = 60 degrees C) were determined by fluorescence spectroscopy. Tc is in close coincidence with the melting temperature of denaturation (Tm = 59 degrees C), determined by circular dichroism (CD) spectroscopy. The free energy of stabilization in water after denaturation with Gdn.HCl was calculated to be 12 k x mol(-1). The specific activity (km values) for D-xylose-glucose isomerase at 70 degrees C toward different substrates, D-xylose, D-glucose, and D-ribose, were determined to be 4.4, 55.5, and 13.3 mM, respectively.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012266 Ribose A pentose active in biological systems usually in its D-form. D-Ribose,D Ribose
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
January 1990, Acta microbiologica Bulgarica,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
January 1987, Acta microbiologica Bulgarica,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
October 1991, Applied biochemistry and biotechnology,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
September 2020, Pakistan journal of pharmaceutical sciences,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
February 2000, Acta crystallographica. Section D, Biological crystallography,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
March 1989, Biochemical and biophysical research communications,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
October 1988, The Journal of biological chemistry,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
January 1994, Chinese journal of biotechnology,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
February 2020, 3 Biotech,
V Raykovska, and P Dolashka-Angelova, and D Paskaleva, and S Stoeva, and J Abashev, and L Kirkov, and W Voelter
January 1987, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!